Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP983277.RA5jsKgjhT-AuU6WHZT8NpzlnwUqQ8bSu29BJbkmwrrsc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP983277.RA5jsKgjhT-AuU6WHZT8NpzlnwUqQ8bSu29BJbkmwrrsc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP983277.RA5jsKgjhT-AuU6WHZT8NpzlnwUqQ8bSu29BJbkmwrrsc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP983277.RA5jsKgjhT-AuU6WHZT8NpzlnwUqQ8bSu29BJbkmwrrsc130_provenance.
- NP983277.RA5jsKgjhT-AuU6WHZT8NpzlnwUqQ8bSu29BJbkmwrrsc130_assertion description "[Thus, access to HCV treatment is of utmost importance in IL28B CC carriers, in whom treatment response is better and in whom progression to cirrhosis might occur more rapidly.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP983277.RA5jsKgjhT-AuU6WHZT8NpzlnwUqQ8bSu29BJbkmwrrsc130_provenance.
- NP983277.RA5jsKgjhT-AuU6WHZT8NpzlnwUqQ8bSu29BJbkmwrrsc130_assertion evidence source_evidence_literature NP983277.RA5jsKgjhT-AuU6WHZT8NpzlnwUqQ8bSu29BJbkmwrrsc130_provenance.
- NP983277.RA5jsKgjhT-AuU6WHZT8NpzlnwUqQ8bSu29BJbkmwrrsc130_assertion SIO_000772 21592993 NP983277.RA5jsKgjhT-AuU6WHZT8NpzlnwUqQ8bSu29BJbkmwrrsc130_provenance.
- NP983277.RA5jsKgjhT-AuU6WHZT8NpzlnwUqQ8bSu29BJbkmwrrsc130_assertion wasDerivedFrom befree-20150227 NP983277.RA5jsKgjhT-AuU6WHZT8NpzlnwUqQ8bSu29BJbkmwrrsc130_provenance.
- NP983277.RA5jsKgjhT-AuU6WHZT8NpzlnwUqQ8bSu29BJbkmwrrsc130_assertion wasGeneratedBy ECO_0000203 NP983277.RA5jsKgjhT-AuU6WHZT8NpzlnwUqQ8bSu29BJbkmwrrsc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP983277.RA5jsKgjhT-AuU6WHZT8NpzlnwUqQ8bSu29BJbkmwrrsc130_provenance.